Interest expense and penalties, net (benefit)/charge recognized
Vertex Pharmaceuticals Interest expense and penalties, net (benefit)/charge recognized remained flat by 0.0% to $3.28M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 131.6%, from -$10.38M to $3.28M. Over 2 years (FY 2023 to FY 2025), Interest expense and penalties, net (benefit)/charge recognized shows a downward trend with a -60.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase in expense signals higher potential costs associated with tax disputes or longer durations of unresolved tax positions.
Detailed definition
This metric tracks the interest and penalties accrued or reversed related to unrecognized tax benefits. It reflects the...
Peer comparison
Standard line item for companies with significant tax contingencies and complex global operations.
other_unrecognized_tax_benefits_income_tax_penalties_and_696650Historical Data
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $84.90M | -$41.50M | $13.10M |
| YoY Change | — | -148.9% | +131.6% |
Interest expense and penalties, net (benefit)/charge recognized at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's interest expense and penalties, net (benefit)/charge recognized?
- Vertex Pharmaceuticals (VRTX) reported interest expense and penalties, net (benefit)/charge recognized of $3.28M in Q4 2025.
- How has Vertex Pharmaceuticals's interest expense and penalties, net (benefit)/charge recognized changed year-over-year?
- Vertex Pharmaceuticals's interest expense and penalties, net (benefit)/charge recognized increased by 131.6% year-over-year, from -$10.38M to $3.28M.
- What is the long-term trend for Vertex Pharmaceuticals's interest expense and penalties, net (benefit)/charge recognized?
- Over 2 years (2023 to 2025), Vertex Pharmaceuticals's interest expense and penalties, net (benefit)/charge recognized has grown at a -60.7% compound annual growth rate (CAGR), from $84.90M to $13.10M.
- What does interest expense and penalties, net (benefit)/charge recognized mean?
- The net expense or benefit from interest and penalties on uncertain tax positions.